secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001683168-22-007257
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 5.01, 5.02, 5.03, 5.06, 7.01, 8.01, 9.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis Therapeutics completes reverse merger with Bull Horn Holdings; now Nasdaq-listed
--------------------------------------------------------------------------------

- Merger closed Oct 28, 2022; Coeptis becomes wholly-owned subsidiary of Bull Horn (renamed Coeptis Therapeutics Holdings).
- Post-merger capital: 19.5M shares outstanding; Coeptis stockholders ~88%, Bull Horn ~12%.
- Pre-closing, Coeptis raised $3.27M via Reg A at $3.00/share and $5.25M from warrant exercises at avg $1.40/share.
- Pipeline: CD38-GEAR-NK (multiple myeloma), CD38-Diagnostic, and SNAP-CAR-T licensed from Univ. of Pittsburgh.
- Board expanded to 7 members; new directors include David Mehalick, Daniel Yerace, Christopher Calise, others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316822007257/0001683168-22-007257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316822007257/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-007257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer